AMGEN at the American Heart Association's (AHA) Scientific Sessions 2022

AHA 2022

November 5–7, Chicago IL, Hybrid

Amgen is proud to be part of the American Heart Association Scientific Sessions 2022. While you are here, you can explore our latest scientific information and disease state education and learn about our long-term commitment to developing and delivering transformative medicines for patients with cardiovascular disease.

Amgen | A Worldwide Pioneer in Biotechnology

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit and follow us on